Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
4/19/2024
Drug R&D and Product Registration News Digest April 2024 (3)
4/12/2024
Drug R&D and Product Registration News Digest April 2024 (2)
4/10/2024
Review of Class 1 New Drug R&D in China 2018-2023
4/5/2024
Drug R&D and Product Registration News Digest April 2024 (1)
4/5/2024
Ascletis Drops FXR Agonist ASC42 After Disappointing Phase II Results
3/30/2024
Drug R&D and Product Registration News Digest March 2024 (4)
3/22/2024
Drug R&D and Product Registration News Digest March 2024 (3)
3/15/2024
Drug R&D and Product Registration News Digest March 2024 (2)
3/8/2024
Drug R&D and Product Registration News Digest March 2024 (1)
3/1/2024
Drug R&D and Product Registration News Digest February 2024 (3)
2/26/2024
Chinese Researchers Made Breakthrough in Biosynthesis of Anticancer Pa...
2/26/2024
Chinese Pharma R&D Investment Grew by Nearly 20% in 2023
2/23/2024
Drug R&D and Product Registration News Digest February 2024 (2)
2/21/2024
Chinese Experts Uncovers Potential Treatment for Osteoporosis in Femal...
2/16/2024
Ethical Concerns Prompt Largest Mass Retraction of Chinese Genetics Pa...
2/10/2024
Drug R&D and Product Registration News Digest February 2024 (1)
2/6/2024
China Nearly Doubles Class 1 New Drugs in 2023
2/1/2024
Drug R&D and Product Registration News Digest January 2024 (5)
1/26/2024
Drug R&D and Product Registration News Digest January 2024 (4)
1/21/2024
Out of the 13 News Drugs in Phase 3 in 12/2023, Six Are from China
1/19/2024
Drug R&D and Product Registration News Digest January 2024 (3)
1/12/2024
Drug R&D and Product Registration News Digest January 2024 (2)
1/8/2024
Pharnexcloud: 18 Domestic New Drugs Likely to be Approved in China 202...
1/8/2024
PharmCube: 20 Blockbuster New Drugs Are Expected to Receive Chinese Ap...
1/7/2024
Drug R&D and Product Registration News Digest January 2024 (1)
12/29/2023
Drug R&D and Product Registration News Digest December 2023 (4)
12/22/2023
Drug R&D and Product Registration News Digest December 2023 (3)
12/19/2023
China Makes Major Breakthrough in Inhalable Vaccine Technology
12/15/2023
Drug R&D and Product Registration News Digest December 2023 (2)
12/12/2023
PLOS Medicine Study Reveals Alarming Use of Inappropriate Control Arms...
Page:
1
/
3
Total number of articles:
75
:
[First]
[<<]
[1]
[2]
[3]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit